Holen Sie sich die Stockscreener-App
98.84
0.25%
0.25
Handel nachbörslich:
98.09
-0.75
-0.76%
Schlusskurs vom Vortag:
$98.59
Offen:
$98.98
24-Stunden-Volumen:
6.94M
Relative Volume:
0.81
Marktkapitalisierung:
$146.46B
Einnahmen:
$19.35B
Nettoeinkommen (Verlust:
$2.78B
KGV:
52.87
EPS:
1.8696
Netto-Cashflow:
$3.49B
1W Leistung:
-2.11%
1M Leistung:
+1.56%
6M Leistung:
-5.80%
1J Leistung:
+16.67%
1-Tages-Spanne:
$98.25
$99.33
1-Wochen-Bereich:
$98.06
$102.27
52-Wochen-Spanne:
$84.13
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Firmenname
Boston Scientific Corp
Sektor
Branche
Telefon
508-683-4000
Adresse
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Vergleichen Sie BSX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
98.84 | 146.15B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
ABT
Abbott Laboratories
|
125.80 | 215.34B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
362.61 | 136.97B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.42 | 115.69B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
84.15 | 48.77B | 5.88B | 1.34B | 577.90M | 2.3455 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-03 | Herabstufung | Erste Group | Buy → Hold |
| 2025-09-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-06-16 | Eingeleitet | Leerink Partners | Outperform |
| 2025-04-16 | Hochstufung | Needham | Hold → Buy |
| 2025-01-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Herabstufung | Needham | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2024-02-01 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-22 | Eingeleitet | Mizuho | Neutral |
| 2022-12-20 | Fortgesetzt | Citigroup | Buy |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-05-27 | Hochstufung | Needham | Hold → Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-05-26 | Herabstufung | Needham | Buy → Hold |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-17 | Eingeleitet | Truist | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-22 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Neutral |
| 2020-02-06 | Fortgesetzt | BTIG Research | Buy |
| 2019-12-30 | Bestätigt | Cowen | Outperform |
| 2019-12-19 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-09-05 | Fortgesetzt | JP Morgan | Overweight |
| 2019-09-03 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-10-02 | Bestätigt | Morgan Stanley | Overweight |
| 2018-09-07 | Bestätigt | Needham | Strong Buy |
| 2018-09-04 | Hochstufung | Jefferies | Hold → Buy |
| 2018-07-06 | Bestätigt | Needham | Strong Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Outperform |
| 2018-04-26 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
Global Pain Management Devices Market Set to Expand Rapidly at a CAGR of ~8% by 2032 Amid Growing Preference for Minimally Invasive Solutions | DelveInsight - GlobeNewswire Inc.
Bank of New York Mellon Corp Has $1.20 Billion Stake in Boston Scientific Corporation $BSX - MarketBeat
Is Boston Scientific Corporation stock ready for a breakoutJuly 2025 Update & Fast Gain Stock Trading Tips - newser.com
Beyond the Balance Sheet: What SWOT Reveals About Boston Scienti - GuruFocus
Boston Scientific announces upcoming investor conference schedule - Financial Times
iA Global Asset Management Inc. Buys 9,476 Shares of Boston Scientific Corporation $BSX - MarketBeat
BOSTON SCIENTIFIC CORP SEC 10-Q Report - TradingView
What earnings revisions data tells us about Boston Scientific CorporationWeekly Profit Recap & Verified Technical Trade Signals - newser.com
October M&A: Bristol Myers, Thermo Fisher, Hologic and Boston Scientific - The Business Journals
Is Boston Scientific Corporation stock a smart buy before Fed meetingWeekly Profit Summary & Verified Swing Trading Watchlist - newser.com
Risk vs reward if holding onto Boston Scientific Corporation2025 Major Catalysts & Smart Money Movement Alerts - newser.com
Technical signs of recovery in Boston Scientific CorporationMarket Risk Report & Free Reliable Trade Execution Plans - newser.com
Do Wall Street Analysts Like Boston Scientific Stock? - MSN
Can Boston Scientific Corporation stock sustain revenue momentumRate Cut & Consistent Growth Stock Picks - newser.com
Can Boston Scientific Corporation stock test all time highs2025 Risk Factors & Long-Term Growth Portfolio Plans - newser.com
Boston Scientific Corporation $BSX Position Boosted by Assetmark Inc. - MarketBeat
World Investment Advisors Raises Stock Position in Boston Scientific Corporation $BSX - MarketBeat
What market sentiment indicators show for Boston Scientific Corporation stockM&A Rumor & Safe Entry Zone Identification - newser.com
Lockheed Martin Investment Management Co. Lowers Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Is Boston Scientific (BSX) Becoming the Leading MedTech Growth Story? - Insider Monkey
Heritage Investors Management Corp Decreases Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
How Boston Scientific Corporation stock moves in volatile trading sessions2025 Trade Ideas & Consistent Growth Equity Picks - newser.com
Buy Boston Scientific Stock. It’s a Way to Diversify From AI? - Barron's
Looking to Diversify Away From AI? Buy Boston Scientific Stock. - Barron's
Chart based analysis of Boston Scientific Corporation trends2025 Price Action Summary & Weekly High Return Forecasts - newser.com
Canaccord Genuity Reiterates a Buy on Boston Scientific Corporation (BSX) - Insider Monkey
OVERSEA CHINESE BANKING Corp Ltd Has $259,000 Holdings in Boston Scientific Corporation $BSX - MarketBeat
5 Insightful Analyst Questions From Boston Scientific’s Q3 Earnings Call - Yahoo Finance
Ellen Zane Sells Shares of Boston Scientific Corp - GuruFocus
Private Wealth Partners LLC Sells 18,631 Shares of Boston Scientific Corporation $BSX - MarketBeat
Will Boston Scientific Corporation stock outperform Nasdaq indexWeekly Investment Summary & Growth Focused Entry Point Reports - fcp.pa.gov.br
BSX Stock Quote Price and Forecast - CNN
Will Boston Scientific Corporation stock gain from strong economyAnalyst Downgrade & Low Risk Profit Maximizing Plans - newser.com
How Boston Scientific Corporation stock performs after earningsJuly 2025 PreEarnings & Smart Money Movement Alerts - fcp.pa.gov.br
EPS Watch: Will Boston Scientific Corporation stock justify high valuationJuly 2025 Earnings & AI Enhanced Trading Alerts - fcp.pa.gov.br
Boston Scientific’s Innovative Approach to Gastric Outlet Obstruction: Study Update - TipRanks
Boston Scientific’s SIMPLAAFY Trial: A New Frontier in Atrial Fibrillation Treatment - TipRanks
Boston Scientific’s Orbera365™ Study: A New Frontier in Weight Loss Management - TipRanks
Boston Scientific’s New Study on Pacemaker Leads: What Investors Need to Know - TipRanks
Boston Scientific’s RHAPSODY Study: A Step Forward in Cardiac Care Innovation - TipRanks
Boston Scientific’s Hot AXIOS™ Stent Study: A Potential Game-Changer in Bile Duct Drainage - TipRanks
Boston Scientific’s Innovative Approach to Atrial Fibrillation: A Study Update - TipRanks
Boston Scientific’s Vercise™ DBS Study: A Real-World Evaluation of Dystonia Treatment - TipRanks
Boston Scientific shares positive Agent drug-coated balloon findings - MassDevice
Does Boston Scientific (BSX) Have the Potential to Rally 25.61% as Wall Street Analysts Expect? - Yahoo Finance
Bessemer Group Inc. Has $313.62 Million Position in Boston Scientific Corporation $BSX - MarketBeat
Schmidt P J Investment Management Inc. Boosts Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Is Boston Scientific Corporation stock a buy in volatile marketsWeekly Trend Recap & Accurate Technical Buy Alerts - newser.com
Prudent Man Advisors LLC Acquires 3,727 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Hits Day High with 3.95% Surge, Outperforming S&P 500 - Markets Mojo
Finanzdaten der Boston Scientific Corp-Aktie (BSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.24%
0.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):